News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Most Asian equity markets rose on Friday amid focus on imminent Iran–U.S. ceasefire talks.
  • Regional bourses are positioned for solid weekly gains.
  • Chinese stocks outperformed after mixed March inflation readings.
  • South Korea led gains as technology stocks rebounded.
  • NIO shares fell after pricing its new ES9 SUV below investor expectations, erasing recent gains.

Latest Articles

Bessent says Trump’s comment on suing Warsh was intended as a joke

Bessent says Trump’s comment on suing Warsh was intended as a joke

U.S. Treasury Secretary Scott Bessent told senators that President Donald Trump was speaking in jest when he suggested he might sue his Federal Reserve chair nominee, Kevin Warsh, if interest rates are not cut. Bessent made the clarification during questioning at a Senate Banking Committee hearing and cited a prior CNBC interview in which he said t…

Once Upon a Farm Shares Jump in NYSE Debut After $197.9 Million Offering

Once Upon a Farm Shares Jump in NYSE Debut After $197.9 Million Offering

Once Upon a Farm Inc opened trading on the New York Stock Exchange at $21, a 17% surge from its $18 IPO price. The Berkeley-based organic childhood nutrition company raised approximately $197.9 million from an offering of about 11 million shares, giving it a market capitalization near $845 million. While sales have climbed rapidly, the company repo…

Poet Technologies: Short the Hype — Betting on Dilution Over Delivery

Poet Technologies: Short the Hype — Betting on Dilution Over Delivery

POET has mobile momentum from AI connectivity narratives, but multiple equity raises, high float, and weak technicals create a setup where dilution outpaces revenue-proof. We outline a mid-term (45 trading days) short trade with entry at $5.75, a $4.00 target and a $6.50 stop loss, supported by capital structure math and recent financing activity.

Agomab Therapeutics Begins Nasdaq Trading Below IPO Price

Agomab Therapeutics Begins Nasdaq Trading Below IPO Price

Agomab Therapeutics NV started trading on the Nasdaq Global Select Market at $14.70 per share, below its $16.00 initial public offering price. The company priced 12,500,000 American Depositary Shares at $16.00 each, with expected gross proceeds of $200.0 million before fees. Underwriters have a 30-day option to buy an additional 1,875,000 ADSs. The…

ZenO Opens Public Beta to Gather First-Person Audio-Visual Data for Physical AI, Built on Story Blockchain

ZenO Opens Public Beta to Gather First-Person Audio-Visual Data for Physical AI, Built on Story Blockchain

ZenO has begun a public beta to collect, anonymize, and structure first-person audio, video, and image data from smart glasses and smartphones to support the training of physical AI systems. The platform leverages Story's Layer-1 blockchain technology for onchain consent and provenance tracking, and the company is participating in the NVIDIA Incept…

Major U.S. Homebuilder Shares Slip After Report of Possible Antitrust Review

Major U.S. Homebuilder Shares Slip After Report of Possible Antitrust Review

Shares of leading U.S. homebuilders fell on Friday after reports surfaced that the White House is weighing an antitrust review of the sector. The potential probe would look at how industry information is exchanged through the trade group Leading Builders of America and comes as the administration increases scrutiny on housing affordability. Several…

Moody's Elevates AbbVie to A2, Assigns Stable Outlook

Moody's Elevates AbbVie to A2, Assigns Stable Outlook

Moody's Ratings raised AbbVie's senior credit rating to A2 from A3 and lifted related debt short-term ratings, citing robust performance in the company's immunology and neuroscience franchises. The agency revised AbbVie's outlook to stable from positive, highlighting continued above-peer earnings growth despite Humira's patent expiration pressures …

Moody's Keeps Coty at Ba1 but Shifts Outlook to Negative

Moody's Keeps Coty at Ba1 but Shifts Outlook to Negative

Moody's has affirmed Coty Inc.'s Ba1 corporate family rating but moved the outlook from stable to negative after the beauty company reported weaker-than-anticipated operating performance. While Moody's highlighted Coty's ability to generate free cash flow and potential interest-cost relief from debt paydown tied to the Wella sale, the rating agency…

London Stocks Close Higher as Mining, Construction and Banking Lead Gains

London Stocks Close Higher as Mining, Construction and Banking Lead Gains

U.K. equities finished the session higher, driven by strength in the Mining, Construction & Materials and Banking sectors. The Investing.com United Kingdom 100 closed up 0.60%, with International Consolidated Airlines Group among the best performers while Relx recorded the steepest decline. Commodities and currency moves included gains in gold and …

Amsterdam stocks climb as AEX advances 1.04% on sector-led gains

Amsterdam stocks climb as AEX advances 1.04% on sector-led gains

The AEX closed higher on Friday, rising 1.04% as broad gains in Basic Materials, Technology and Industrials lifted the market. ArcelorMittal reached a five-year high, while several information and publishing names registered declines and three-year lows. Commodity and currency markets also moved, with crude, Brent and gold posting gains and the U.S…